# Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population

> **NCT06371170** · — · RECRUITING · sponsor: **Azienda Ospedaliero, Universitaria Ospedali Riuniti** · enrollment: 20 (estimated)

## Conditions studied

- Intracardiac Thrombus

## Interventions

- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT06371170
- **Lead sponsor:** Azienda Ospedaliero, Universitaria Ospedali Riuniti
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06371170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06371170, "Rivaroxaban for Intracardiac Thrombosis in the Pediatric Population". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06371170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*